Literature DB >> 18247554

Histone deacetylase inhibitors: from bench to clinic.

Marielle Paris1, Marina Porcelloni, Monica Binaschi, Daniela Fattori.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18247554     DOI: 10.1021/jm7011408

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  70 in total

Review 1.  Discovery and mechanism of natural products as modulators of histone acetylation.

Authors:  Lilibeth A Salvador; Hendrik Luesch
Journal:  Curr Drug Targets       Date:  2012-07       Impact factor: 3.465

2.  Synthesis, molecular docking and biological evaluation as HDAC inhibitors of cyclopeptide mimetics by a tandem three-component reaction and intramolecular [3+2] cycloaddition.

Authors:  Tracey Pirali; Valeria Faccio; Riccardo Mossetti; Ambra A Grolla; Simone Di Micco; Giuseppe Bifulco; Armando A Genazzani; Gian Cesare Tron
Journal:  Mol Divers       Date:  2009-05-28       Impact factor: 2.943

Review 3.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

4.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

5.  Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor.

Authors:  Wenwen Duan; Jin Li; Elizabeth S Inks; C James Chou; Yuping Jia; Xiaojing Chu; Xiaoyang Li; Wenfang Xu; Yingjie Zhang
Journal:  J Med Chem       Date:  2015-05-07       Impact factor: 7.446

Review 6.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

Review 7.  Epigenome manipulation as a pathway to new natural product scaffolds and their congeners.

Authors:  Robert H Cichewicz
Journal:  Nat Prod Rep       Date:  2009-10-27       Impact factor: 13.423

8.  Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.

Authors:  Ana Montero; John M Beierle; Christian A Olsen; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2009-03-04       Impact factor: 15.419

9.  Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with Indole-Containing Cap Group.

Authors:  Yingjie Zhang; Penghui Yang; C James Chou; Chunxi Liu; Xuejian Wang; Wenfang Xu
Journal:  ACS Med Chem Lett       Date:  2013-01-08       Impact factor: 4.345

10.  Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.

Authors:  Shinya Hayami; Masanori Yoshimatsu; Abhimanyu Veerakumarasivam; Motoko Unoki; Yukiko Iwai; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Hiroki Yamaue; Bruce A J Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Mol Cancer       Date:  2010-03-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.